Dan Chen
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Hematology 10
- Platelet Disorders and Treatments 3
- Immunology 12
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Co-authors
- Fengtao You (3 shared papers)Gangli An (3 shared papers)Licui Jiang (3 shared papers)Huimin Meng (3 shared papers)Lin Yang (3 shared papers)Yueqing Gu (1 shared paper)Bowen Li (1 shared paper)Min Zhang (1 shared paper)
- Journals
- Blood (2 papers)Frontiers in Immunology (2 papers)Clinical and Translational Medicine (1 paper)Cell Death and Disease (1 paper)Pathogens (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dan Chen
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Oncology 370
- Immunology 244
- Cancer Research 153
- Hematology 114
- Rheumatology 91
Countries citing papers authored by Dan Chen
This map shows the geographic impact of Dan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Chen more than expected).
Fields of papers citing papers by Dan Chen
This network shows the impact of papers produced by Dan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Chen. The network helps show where Dan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 136 | |
| 2 | A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia. | 2019 | 120 |
| 3 | 2015 | 98 | |
| 4 | 2017 | 96 | |
| 5 | 2021 | 53 | |
| 6 | 2015 | 51 | |
| 7 | 2013 | 46 | |
| 8 | 2015 | 45 | |
| 9 | 2022 | 40 | |
| 10 | 2019 | 38 | |
| 11 | 2017 | 35 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 32 | |
| 14 | 2022 | 31 | |
| 15 | 2017 | 30 | |
| 16 | 2011 | 25 | |
| 17 | MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity. | 2021 | 25 |
| 18 | 2014 | 25 | |
| 19 | Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis. | 2014 | 22 |
| 20 | 2015 | 22 |
About Dan Chen
Dan Chen is a scholar working on Hematology, Immunology, Oncology, Genetics and Orthopedics and Sports Medicine, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (4 papers), MicroRNA in disease regulation (4 papers), Bone and Joint Diseases (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Platelet Disorders and Treatments (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Oncology (370 citations), Immunology (244 citations), Cancer Research (153 citations), Hematology (114 citations) and Rheumatology (91 citations). Dan Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fengtao You, Gangli An, Licui Jiang, Huimin Meng, Lin Yang, Yueqing Gu, Bowen Li, Min Zhang, Haiyan Chen and Yuheng Wang. Their work appears in journals such as Blood, Frontiers in Immunology, Clinical and Translational Medicine, Cell Death and Disease and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.